Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Amgen To Rapidly Move Olpasiran Into Phase III For Lp(a) Reduction
May 31 2022
•
By
Jessica Merrill
Amgen is advancing olpasiran into Phase III • Source: Shutterstock
More from Strategy
More from Business